Additionally, it is reported that destroying PD-1 enhances the anti-tumor activity of CAR-T cells against hepatocellular carcinoma in vivo, and improves the persistence and infiltration of CAR T cells in tumors [145]. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.